Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
暂无分享,去创建一个
Yan Gao | Shuhua Yang | Zhenfeng Duan | Xiaoqian Yang | H. Mankin | Yan Gao | Z. Duan | F. Hornicek | Xiaoqian Yang | Francis J Hornicek | Shuhua Yang | Yong Feng | Slim Sassi | Jacson K Shen | Eiji Osaka | Jianming Zhang | Cao Yang | Henry J Mankin | Jianming Zhang | Jacson K. Shen | S. Sassi | E. Osaka | Yong Feng | Cao Yang | H. Mankin‡
[1] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[2] R. Gorlick,et al. Osteosarcoma: a review of diagnosis, management, and treatment strategies. , 2010, Clinical advances in hematology & oncology : H&O.
[3] Quan Tian,et al. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells , 2010, Investigational New Drugs.
[4] Xin Zhang,et al. Targeted mutagenesis in rice using CRISPR-Cas system , 2013, Cell Research.
[5] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[6] M. Manoharan,et al. RNAi therapeutics: a potential new class of pharmaceutical drugs , 2006, Nature chemical biology.
[7] S. T. Kim,et al. CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11p110 , 2014, Oncogene.
[8] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[9] X. Zi,et al. Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma , 2010, Molecular Cancer Therapeutics.
[10] P. Picci,et al. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity , 2007, Oncogene.
[11] Guang-Yuh Chiou,et al. Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy. , 2012, Current gene therapy.
[12] F. Zhang,et al. CRISPR/Cas9 for genome editing: progress, implications and challenges. , 2014, Human molecular genetics.
[13] Inder M. Verma,et al. Gene therapy: trials and tribulations , 2000, Nature Reviews Genetics.
[14] R. Barrangou,et al. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. , 2011, Annual review of genetics.
[15] Yarden Katz,et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system , 2013, Cell Research.
[16] J. Doudna,et al. RNA-guided genetic silencing systems in bacteria and archaea , 2012, Nature.
[17] Q. Kan,et al. Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells. , 2014, Cancer letters.
[18] P. Loyer,et al. Characterization of Cyclin L1 and L2 Interactions with CDK11 and Splicing Factors , 2008, Journal of Biological Chemistry.
[19] S. Kumta,et al. Alendronate regulates cell invasion and MMP‐2 secretion in human osteosarcoma cell lines , 2004, Pediatric blood & cancer.
[20] Martin J. Aryee,et al. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing , 2014, Nature Biotechnology.
[21] Josée Dostie,et al. Repurposing CRISPR/Cas9 for in situ functional assays , 2013, Genes & development.
[22] H. van Bakel,et al. Cdk11-cyclinL controls the assembly of the RNA polymerase II mediator complex. , 2012, Cell reports.
[23] Jeffry D. Sander,et al. CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.
[24] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[25] K. Ryan,et al. The cyclin-dependent kinase PITSLRE/CDK11 is required for successful autophagy , 2011, Autophagy.
[26] Chad A. Cowan,et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. , 2013, Cell stem cell.
[27] I. Lewis,et al. Osteosarcoma treatment - where do we stand? A state of the art review. , 2014, Cancer treatment reviews.
[28] P. Lollini,et al. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity , 2014, Oncogene.
[29] A. Inoue,et al. Failure To Proliferate and Mitotic Arrest of CDK11p110/p58-Null Mutant Mice at the Blastocyst Stage of Embryonic Cell Development , 2004, Molecular and Cellular Biology.
[30] H. Mankin,et al. MicroRNA‐1 (miR‐1) inhibits chordoma cell migration and invasion by targeting slug , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[31] P. Lollini,et al. CD99 acts as an oncosuppressor in osteosarcoma. , 2006, Molecular biology of the cell.
[32] Yoshio Koyanagi,et al. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus , 2013, Scientific Reports.
[33] M. Kimura,et al. Generation of an ICF Syndrome Model by Efficient Genome Editing of Human Induced Pluripotent Stem Cells Using the CRISPR System , 2013, International journal of molecular sciences.
[34] Young-Chae Chang,et al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. , 2007, Journal of biochemistry and molecular biology.
[35] Luke A. Gilbert,et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.
[36] Rudolf Jaenisch,et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.
[37] Chenguang Wang,et al. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. , 2010, Cancer research.
[38] George A. Calin,et al. RNA interference in the clinic: challenges and future directions , 2011, Nature Reviews Cancer.
[39] D. Campana,et al. PITSLRE protein kinase activity is associated with apoptosis , 1995, Molecular and cellular biology.
[40] M. Boutros,et al. A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis , 2014, The EMBO journal.
[41] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[42] W. El-Deiry,et al. CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth , 2013, Cell cycle.
[43] N. Gray,et al. Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation , 2012, Clinical Cancer Research.
[44] S. Jung,et al. Risedronate inhibits human osteosarcoma cell invasion , 2009, Journal of experimental & clinical cancer research : CR.
[45] Huitu Liu,et al. Cellular and molecular evidence for malignancy-inhibitory functions of p15RS , 2012, Cell cycle.
[46] A. Montag,et al. Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcoma , 2002, International journal of cancer.
[47] T. Ishida,et al. Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis , 2004, Clinical & Experimental Metastasis.
[48] M. Nelson,et al. Regulation of stability of cyclin-dependent kinase CDK11p110 and a caspase-processed form, CDK11p46, by Hsp90. , 2004, The Biochemical journal.
[49] J. Wang,et al. Downregulation of p57kip2 promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells , 2011, Journal of cellular biochemistry.